Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · IEX Real-Time Price · USD
14.01
-0.09 (-0.64%)
At close: Jul 2, 2024, 4:00 PM
14.03
+0.02 (0.14%)
After-hours: Jul 2, 2024, 7:07 PM EDT
Elanco Animal Health Revenue
Elanco Animal Health had revenue of $4.37B in the twelve months ending March 31, 2024, down -1.76% year-over-year. Revenue in the quarter ending March 31, 2024 was $1.21B, a -4.14% decrease year-over-year. In the year 2023, Elanco Animal Health had annual revenue of $4.42B with 0.14% growth.
Revenue (ttm)
$4.37B
Revenue Growth
-1.76%
P/S Ratio
1.59
Revenue / Employee
$445,408
Employees
9,800
Market Cap
6.92B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.42B | 6.00M | 0.14% |
Dec 31, 2022 | 4.41B | -353.00M | -7.41% |
Dec 31, 2021 | 4.76B | 1.49B | 45.64% |
Dec 31, 2020 | 3.27B | 200.00M | 6.51% |
Dec 31, 2019 | 3.07B | 4.20M | 0.14% |
Dec 31, 2018 | 3.07B | 177.80M | 6.15% |
Dec 31, 2017 | 2.89B | -24.50M | -0.84% |
Dec 31, 2016 | 2.91B | 4.40M | 0.15% |
Dec 31, 2015 | 2.91B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Ensign Group | 3.85B |
Jazz Pharmaceuticals | 3.84B |
Bio-Rad Laboratories | 2.61B |
Penumbra | 1.10B |
HealthEquity | 1.04B |
Ionis Pharmaceuticals | 776.62M |
Repligen | 607.45M |
Intra-Cellular Therapies | 513.93M |
ELAN News
- 11 hours ago - ELAN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Elanco Animal Health Incorporated investment - GlobeNewsWire
- 14 hours ago - Levi & Korsinsky Investigates Possible Securities Fraud Violations by Elanco Animal Health Incorporated (ELAN) - Accesswire
- 15 hours ago - ELAN INVESTOR INQUIRY: BFA Law Alerts Elanco (NYSE:ELAN) Investors with Losses that it is Investigating the Company for Securities Fraud – Contact Us for Details - Accesswire
- 15 hours ago - Investors who lost money on Elanco Animal Health Incorporated should contact Levi & Korsinsky about an ongoing investigation - ELAN - Accesswire
- 15 hours ago - Shareholder Rights Advocates at Levi & Korsinsky Investigate Elanco Animal Health Incorporated (ELAN) Regarding Possible Securities Fraud Violations - Accesswire
- 16 hours ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Elanco Animal Health Incorporated - ELAN - PRNewsWire
- 1 day ago - ELANCO ALERT: Bragar Eagel & Squire, P.C. is Investigating Elanco Animal Health Incorporated on Behalf of Elanco Stockholders and Encourages Investors to Contact the Firm - GlobeNewsWire
- 1 day ago - Elanco Being Investigated on Behalf of Elanco Animal Health Incorporated Investors. Contact Levi & Korsinsky For Details - Accesswire